Clinically Occult Cecal Metastasis From Prostate Adenocarcinoma Detected by 18F-PSMA Positron Emission Tomography at Biochemical Recurrence
We present a patient with biochemical recurrence after salvage radiation and combined androgen deprivation therapy with abiraterone who underwent 18 F-PSMA PET/CT for a rapidly rising prostate-specific antigen (PSA). The scan revealed an intense prostate-specific membrane antigen (PSMA)-avid focus in the cecum without an apparent CT correlate. Colonoscopy identified a smooth, 2 cm nonobstructing cecal mass, and biopsy confirmed metastatic prostate adenocarcinoma by morphology and immunohistochemistry. This case demonstrates 18 F-PSMA PET/CT detection at a low PSA level of a clinically occult metastatic lesion involving the cecum, an exceptionally rare site for prostate cancer spread. Colonoscopy and biopsy confirmation of atypical PSMA-avid gastrointestinal lesions remain essential, as physiologic colonic uptake, PSMA-avid diverticula, and PSMA-expressing primary colorectal cancers are well-documented mimickers.
Authors
- Ai Phuong Tong (ORCID: https://orcid.org/0000-0002-2771-9504)
- Fatemeh (Sanaz) Behnia
Publication Details
- Journal
- Clinical Nuclear Medicine
- Published
- 2026-11-09
- DOI
- https://doi.org/10.1097/rlu.0000000000006785
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00